Daily aspirin could lower ovarian cancer risk
Women may be able to reduce their risk of ovarian cancer by taking low-dose aspirin on a daily basis, according to new research.
Investigators analyzed data from 12 studies that collectively involved almost 8,000 women with ovarian cancer and almost 12,000 women without cancer. The researchers examined whether ovarian cancer was linked to the use of aspirin, non-aspirin NSAIDS (non-steroidal anti-inflammatory drugs) or acetaminophens. They found that the women who took a low dose of aspirin every day reduced their risk of ovarian cancer by 20 percent, when compared with the women who took aspirin less than once a week. The women who took NSAIDS reduced their risk of ovarian cancer by a small percentage, which researchers said was not “statistically significant.” Acetaminophens seemed to have no effect.
The study’s findings, published in the Journal of the National Cancer Institute, suggest that aspirin could help prevent ovarian cancer—a disease that affected more than 20,000 women in the U.S. last year and is expected to be fatal for more than 14,000 women in 2014. However, researchers warn women to check with their doctors before starting a daily aspirin regimen.